U.S., Aug. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07770360) titled 'Performance Study of the INSTI(R) and TruPlex Rapid Blood Typing Platforms' on July 28.
Brief Summary: CLS-019A is a prospective, multi-site, parallel clinical performance study. Each enrolled subject is tested on both investigational devices in parallel within a single study visit, yielding paired INSTI(R) and TruPlex results from matched capillary fingerstick and EDTA-VWB samples.
Study Start Date: Aug. 31
Study Type: INTERVENTIONAL
Condition:
ABO Blood Type
RhD Blood Type
Intervention:
DIAGNOSTIC_TEST: INSTI(R) Rapid Blood Type Test
A flow-through blood grouping reagent device intended for the determination of ABO and RhD ...